Search

  1. About ProQR Therapeutics

    Page

    An innovative biotech company advancing our proprietary Axiomer RNA-editing platform technology.

    Female scientist working in ProQR's laboratories

  2. ProQR founding story

    Page

    When our CEO, Daniel A. de Boer, knew his newborn son had an incurable rare disease, he founded ProQR to help people like his son. Learn more.

    Daniel de Boer, CEO of ProQR Therapeutics

  4. ProQR Analyst Event

    Webcast

    During this webcast ProQR leadership will highlight key advancements from its clinical-stage pipeline and Axiomer® RNA editing platform.

  5. ProQR Update August 2022

    Community news

    … ProQR Update August 2022 Announced today (August 11, 2022), ProQR will focus exclusively on the development of the … from the European Medicines Agency (EMA) related to ProQR’s sepofarsen for Leber Congenital Amaurosis type 10 …

    RNA illustration

  6. Building an Inclusive ProQR

    Blog

    … Building an Inclusive ProQR At ProQR we strive to create an inclusive culture where everyone … logo to incorporate the pride rainbow flag. Pride month at ProQR is an opportunity to celebrate and thank all of the …

    Rainbow image with text We Wish You A Happy Pride Month!

  8. ProQR Therapeutics Virtual R&D Event 2023

    Webcast

    … ProQR Therapeutics Virtual R&D Event 2023 ProQR will host a virtual R&D event on Wednesday, March 29, … under “Events” in the “Investors & Media” section of ProQR’s website at www.proqr.com/events . The presentation is …

  10. ProQR recognised as a Great Place To Work

    News update

    In April 2025, ProQR received the Great Place To Work (GPTW) certification following the results of the employee survey from GPTW Netherlands.

    ProQR recognised as a Great Place To Work